| Rapid Critical Metals Limited (RCM) ORDINARY FULLY PAID |
Materials |
$37 |
Silver Acquisition Completion & Appointment of New MD
|
25 Jul 2025 8:42AM |
$0.029 |
$0.031 |
risen by
6.90%
|
|
RCM - Price-sensitive ASX Announcement
Full Release
Key Points
- Completion of a significant silver asset acquisition by Rapid Critical Metals Limited.
- Appointment of a new Managing Director to lead the company.
- The acquisition is expected to enhance the company's portfolio and growth prospects.
- Background information provided on the new Managing Director and his industry experience.
- The company reinforces its strategy to focus on critical and precious metals.
- Shareholders and stakeholders are anticipated to benefit from the transaction.
- The announcement aligns with Rapid Critical Metals Limited's long-term growth objectives.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| WAM Income Maximiser Limited (WMX) ORDINARY FULLY PAID |
Financials |
$332 |
Notice of Extraordinary General Meeting and Proxy Form
|
25 Jul 2025 8:41AM |
$1.675 |
$1.715 |
risen by
2.39%
|
|
| BlinkLab Limited (BB1) ORDINARY FULLY PAID |
Health Care |
$90 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
25 Jul 2025 8:41AM |
$0.480 |
$0.590 |
risen by
22.92%
|
|
BB1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Clinical validation studies advanced in the United States and Europe.
- Key milestones achieved in the development and deployment of digital diagnostic technology.
- New partnerships and expanded research collaborations reported.
- Operational expenditure focused on research and development, administration, and staffing.
- Cash flow position and funding outcomes disclosed as per ASX requirements.
- Ongoing focus on commercialization of digital diagnostics for neurological and psychiatric disorders.
- Report includes Appendix 4C as mandated by the ASX.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| FleetPartners Group Limited (FPR) ORDINARY FULLY PAID |
Financials |
$600 |
Update - Notification of buy-back - FPR
|
25 Jul 2025 8:40AM |
$2.820 |
$2.810 |
fallen by
0.35%
|
|
| Far Limited (FAR) ORDINARY FULLY PAID |
Energy |
$27 |
Quarterly Activities Report and Appendix 5B
|
25 Jul 2025 8:37AM |
$0.410 |
$0.295 |
fallen by
28.05%
|
|
FAR - Price-sensitive ASX Announcement
Full Release
Key Points
- Far Limited issued its Quarterly Activities Report and Appendix 5B for the quarter ended 31 December 2023.
- The company maintained focus on oil and gas exploration and development, primarily in Africa.
- Efforts to maximise shareholder value included asset management, cost reductions, and the pursuit of new business opportunities.
- The report highlights ongoing financial discipline with cash flow management and expenditure controls.
- Updates provided on significant projects and divestment activities.
- Appendix 5B presents details of cash flows, operational spending, and investment transactions for the quarter.
- The report complies with the reporting requirements of the Australian Securities Exchange (ASX).
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Aristocrat Leisure Limited (ALL) ORDINARY FULLY PAID |
Consumer Discretionary |
$36,441 |
Update - Notification of buy-back - ALL
|
25 Jul 2025 8:36AM |
$67.450 |
$60.790 |
fallen by
9.87%
|
|
| Island Pharmaceuticals Limited (ILA) ORDINARY FULLY PAID |
Health Care |
$118 |
Change of Director's Interest Notice - JC
|
25 Jul 2025 8:36AM |
$0.170 |
$0.400 |
risen by
135.29%
|
|
| Dimerix Limited (DXB) ORDINARY FULLY PAID |
Health Care |
$150 |
Quarterly Appendix 4C and Activities Report
|
25 Jul 2025 8:35AM |
$0.550 |
$0.250 |
fallen by
54.55%
|
|
DXB - Price-sensitive ASX Announcement
Full Release
Key Points
- Dimerix Limited (DXB) released its Appendix 4C and Quarterly Activities Report for the quarter ending 31 March 2024.
- The company continued progression of its Phase 3 ACTION3 clinical trial evaluating DMX-200 in patients with FSGS kidney disease, maintaining recruitment momentum across global sites.
- Dimerix reported continued engagement with regulators and key opinion leaders to advance development and commercial pathways for DMX-200.
- The company highlighted strategic partnerships, with the FSGS trial being conducted under an agreement with the global pharmaceutical company Advanz Pharma.
- Cash receipts from customers for the quarter totaled $0.09 million, with net cash used in operating activities at $4.13 million.
- Dimerix ended the quarter with a cash balance of $7.14 million, which is expected to fund ongoing operations and clinical development.
- No revenue was generated from product sales during the period, with cash outflows primarily related to research, development, and clinical trial activities.
- The company continued to evaluate additional opportunities for its DMX-200 asset, including in other kidney diseases and acute respiratory distress syndrome (ARDS).
- Payments to related parties and their associates during the quarter amounted to $0.19 million, covering directors’ fees, salaries, and consulting services.
- Dimerix remains focused on executing its clinical and commercial strategies, with a view to delivering value to shareholders and addressing unmet medical needs.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Intelligent Monitoring Group Limited (IMB) ORDINARY FULLY PAID |
Industrials |
$247 |
Notification of buy-back - IMB
|
25 Jul 2025 8:35AM |
$0.485 |
$0.600 |
risen by
23.71%
|
|
| Urbanise.Com Limited (UBN) ORDINARY FULLY PAID |
Information Technology |
$51 |
CFO Transition
|
25 Jul 2025 8:34AM |
$0.850 |
$0.640 |
fallen by
24.71%
|
|
| Mithril Silver and Gold Limited (MTH) ORDINARY FULLY PAID |
Materials |
$41 |
Notification regarding unquoted securities - MTH
|
25 Jul 2025 8:32AM |
$0.530 |
$0.220 |
fallen by
58.49%
|
|
| Collins Foods Limited (CKF) ORDINARY FULLY PAID |
Consumer Discretionary |
$910 |
2025 Notice of AGM and Proxy Form
|
25 Jul 2025 8:31AM |
$9.120 |
$7.700 |
fallen by
15.57%
|
|
| Stockland (SGP) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$10,043 |
Update - Dividend/Distribution - SGP
|
25 Jul 2025 8:31AM |
$5.420 |
$4.130 |
fallen by
23.80%
|
|
| Catalyst Metals Limited (CYL) ORDINARY FULLY PAID |
Materials |
$1,471 |
Section 708A notice
|
25 Jul 2025 8:30AM |
$4.930 |
$5.630 |
risen by
14.20%
|
|
| Astral Resources NL (AAR) ORDINARY FULLY PAID |
Materials |
$252 |
Noosa Mining Conference Presentation
|
25 Jul 2025 8:30AM |
$0.160 |
$0.140 |
fallen by
12.50%
|
|
| Whitehaven Coal Limited (WHC) ORDINARY FULLY PAID |
Energy |
$6,373 |
June 2025 Quarterly Report
|
25 Jul 2025 8:30AM |
$7.030 |
$7.750 |
risen by
10.24%
|
|
WHC - Price-sensitive ASX Announcement
Full Release
Key Points
- Whitehaven Coal's FY25 ROM coal production and coal sales exceeded guidance expectations.
- Unaudited unit costs and capital expenditure for FY25 were below the projected range.
- FY25 managed ROM coal production reached 39.1 Mt, with QLD operations producing 20.0 Mt and NSW operations 19.1 Mt.
- Managed coal sales totaled 30.2 Mt for FY25, with QLD and NSW operations contributing 15.8 Mt and 14.4 Mt respectively.
- Unaudited unit costs of coal (excluding royalties) were $139/t, and capital expenditure was approximately $390 million.
- QLD operations showed significant improvements with a 26% increase in ROM production during the June quarter.
- Whitehaven Coal plans to present FY25 financial results and FY26 guidance on 21 August 2025.
- The announcement is authorized for release by the Board of Whitehaven Coal Limited.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Whitehaven Coal Limited (WHC) ORDINARY FULLY PAID |
Energy |
$6,373 |
June 2025 Quarterly Report
|
25 Jul 2025 8:30AM |
$7.030 |
$7.750 |
risen by
10.24%
|
|
WHC - Price-sensitive ASX Announcement
Full Release
Key Points
- Whitehaven Coal Limited's Q4 FY25 production and sales were strong, meeting or exceeding guidance targets.
- The company reported a FY25 total recordable injury frequency rate (TRIFR) of 4.6 for employees and contractors.
- Managed ROM production for the June quarter was 10.6Mt, up 15% on the March quarter, and 39.1Mt for FY25, up 60% on FY24.
- FY25 revenue mix consisted of approximately 64% metallurgical coal and 36% thermal coal sales.
- QLD operations exceeded production guidance, with a managed ROM production of 20.0Mt for FY25.
- NSW operations also performed well, with FY25 ROM production of 19.1Mt, aligning closely with FY24.
- Managed coal sales reached 30.2Mt in FY25, with an equity sale of 26.5Mt.
- The company maintained a strong financial position with net debt of $0.6 billion as of 30 June 2025.
- Whitehaven achieved a FY25 unit cost of coal of approximately $139/t, better than guidance.
- The first deferred payment of US$500 million was paid in April 2025, with a contingent payment of US$9 million paid in July 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Westpac Banking Corporation (WBC) ORDINARY FULLY PAID |
Financials |
$127,030 |
Update - Notification of buy-back - WBC
|
25 Jul 2025 8:29AM |
$33.290 |
$37.140 |
risen by
11.57%
|
|
| Steadfast Group Limited (SDF) ORDINARY FULLY PAID |
Financials |
$5,782 |
Steadfast Group Chief Financial Officer Retirement
|
25 Jul 2025 8:28AM |
$5.910 |
$5.200 |
fallen by
12.01%
|
|
| NOVONIX Limited (NVX) ORDINARY FULLY PAID |
Information Technology |
$145 |
Notice under section 708A(5)(e)
|
25 Jul 2025 8:28AM |
$0.555 |
$0.145 |
fallen by
73.87%
|
|
| Mithril Silver and Gold Limited (MTH) ORDINARY FULLY PAID |
Materials |
$41 |
CLOSING OF C$11.5 MILLION BROKERED PRIVATE PLACEMENT
|
25 Jul 2025 8:27AM |
$0.530 |
$0.220 |
fallen by
58.49%
|
|
MTH - Price-sensitive ASX Announcement
Full Release
Key Points
- Mithril Silver and Gold Limited closed a C$11.5 million brokered private placement.
- Cormark Securities Inc. acted as the lead underwriter, with a syndicate of underwriters involved.
- Funds will be directed towards the Copalquin Gold-Silver Project in Mexico.
- Proceeds will be used for further drilling, resource definition, project development, and working capital.
- The placement underscores investor confidence in Mithril Silver and Gold Limited's growth strategy.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Catalyst Metals Limited (CYL) ORDINARY FULLY PAID |
Materials |
$1,471 |
Application for quotation of securities - CYL
|
25 Jul 2025 8:27AM |
$4.930 |
$5.630 |
risen by
14.20%
|
|
| Lanthanein Resources Ltd (LNR) ORDINARY FULLY PAID |
Materials |
- |
Quarterly Activities/Appendix 5B Cash Flow Report
|
25 Jul 2025 8:26AM |
$0.001 |
$0.067 |
risen by
6,600%
|
|
LNR - Price-sensitive ASX Announcement
Full Release
Key Points
- Exploration focus remained on rare earth and critical minerals projects in Western Australia and South Australia.
- Drilling and sampling programs were ongoing at Lyons and Gascoyne projects.
- Soil geochemistry and reconnaissance activities continued at Murraydium and Calyerup Creek projects.
- Engagement with traditional owners and stakeholders was ongoing.
- Cash outflows were primarily related to exploration and project administration.
- No mining production or development activities occurred during the quarter.
- No new tenement acquisitions or disposals were made.
- Cash balance at the end of the quarter was sufficient to support ongoing operations.
- No significant environmental or community issues were reported.
- Payments to related parties were limited to director fees.
- Commitment to responsible exploration and systematic advancement of the project portfolio.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Barton Gold Holdings Limited (BGD) ORDINARY FULLY PAID |
Materials |
$199 |
Wudinna Gold Project Rights Acquisition Completed
|
25 Jul 2025 8:26AM |
$0.720 |
$0.735 |
risen by
2.08%
|
|
BGD - Price-sensitive ASX Announcement
Full Release
Key Points
- Barton Gold Holdings Limited has acquired the remaining 20% interest in the Wudinna Gold Project.
- The company now owns 100% of the Wudinna Gold Project in South Australia.
- The acquisition was made through an agreement with the previous minority owner.
- Full ownership is expected to streamline project management and operational activities.
- The acquisition aligns with Barton’s strategic objectives for gold exploration and development.
- The Wudinna Gold Project is considered a key asset in Barton's portfolio.
- Barton reaffirms its commitment to further exploration, development, and value creation at the project.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Intelligent Monitoring Group Limited (IMB) ORDINARY FULLY PAID |
Industrials |
$247 |
IMB - Coffee MicroCaps Webinar Presentation
|
25 Jul 2025 8:25AM |
$0.485 |
$0.600 |
risen by
23.71%
|
|
Call 1300 880 160
Start a chat
Schedule a call
